Bakhuraysah, Maha M.
Theotokis, Paschalis http://orcid.org/0000-0001-8607-6695
Lee, Jae Young
Alrehaili, Amani A.
Aui, Pei-Mun
Figgett, William A.
Azari, Michael F.
Abou-Afech, John-Paul
Mackay, Fabienne
Siatskas, Christopher
Alderuccio, Frank
Strittmatter, Stephen M.
Grigoriadis, Nikolaos
Petratos, Steven http://orcid.org/0000-0003-1211-4577
Funding for this research was provided by:
Multiple Sclerosis Research Australia and Trish Multiple Sclerosis Research Foundation (#15-022, #15-022)
National Institutes of Health
National Multiple Sclerosis Society, United Sates (#RG4398A1/1)
International Progressive Multiple Sclerosis Alliance Challenge Award (#PA0065)
Bethlehem Griffiths Research Foundation (#BGRF1706)
Article History
Received: 15 December 2019
Accepted: 14 January 2021
First Online: 3 February 2021
Competing interests
: The authors declare that S.M.S. is a co-founder and consultant for ReNetX Bio, which seeks to develop NgR1-based therapies for neural repair. All other authors listed do not have competing interests.